From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan

Taiwanese Journal of Obstetrics and Gynecology

Volumn 52, Issue 4, 2013, Pages 470-474

  Shaw, S W Steven ^a   Chen, Chih Ping ^b,c,d,e   Cheng, Po Jen ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Down syndrome; First and second trimester screening; Noninvasive prenatal testing

Indexed keywords

AMNIOCENTESIS; CHORION VILLUS SAMPLING; DOWN SYNDROME; EDWARDS SYNDROME; FIRST TRIMESTER PREGNANCY; HUMAN; NON INVASIVE PROCEDURE; NONINVASIVE PRENATAL TEST; PILOT STUDY; PRENATAL SCREENING; REVIEW; SECOND TRIMESTER PREGNANCY; TAIWAN;

DOWN SYNDROME; FIRST AND SECOND TRIMESTER SCREENING; NONINVASIVE PRENATAL TESTING;

DOWN SYNDROME; FEMALE; GENETIC TESTING; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY; TAIWAN;

EID: 84892370671     PISSN: 10284559     EISSN: 18756263     Source Type: Journal    
DOI: 10.1016/j.tjog.2013.10.003     Document Type: Review

References (44)

1. Korenberg J.R., Chen X.N., Schipper R., Sun Z., Gonsky R., Gerwehr S. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci USA 1994, 91:4997-5001.
2. Chen B.Y., Hwang B.F., Guo Y.L. Epidemiology of congenital anomalies in a population-based birth registry in Taiwan. J Formos Med Assoc 2009, 108:460-468.
3. Martin J.A., Hamilton B.E., Sutton P.D., Ventura S.J., Menacker F., Munson M.L. Births: final data for 2002. Natl Vital Stat Rep 2003, 52:1-113.
4. Wald N.J., Watt H.C., Hackshaw A.K. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 1999, 341:461-467.
5. Jou H.J., Shyu M.K., Chen S.M., Shih J.C., Hsu J.J., Hsieh F.J. Maternal serum screening for Down syndrome by using alpha-fetoprotein and human chorionic gonadotropin in an Asian population. A prospective study. Fetal Diagn Ther 2000, 15:108-111.
6. Hsu J.J., Hsieh T.T., Hsieh F.J. Down syndrome screening in an Asian population using alpha-fetoprotein and free beta-hCG: a report of the Taiwan Down Syndrome Screening Group. Obstet Gynecol 1996, 87:943-947.
7. Jou H.J., Kuo Y.S., Hsu J.J., Shyu M.K., Hsieh T.T., Hsieh F.J. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening. Prenat Diagn 2005, 25:665-670.
8. Shaw S.W., Hsu J.J., Lee C.N., Hsiao C.H., Chen C.P., Hsieh T.T., et al. First- and second-trimester Down syndrome screening: current strategies and clinical guidelines. Taiwan J Obstet Gynecol 2008, 47:157-162.
9. Wald N.J. First-trimester screening for Down's syndrome. N Engl J Med 2004, 350:619-621. author reply 621.
10. Shaw S.W., Lin S.Y., Lin C.H., Su Y.N., Cheng P.J., Lee C.N., et al. Second-trimester maternal serum quadruple test for Down syndrome screening: a Taiwanese population-based study. Taiwan J Obstet Gynecol 2010, 49:30-34.
11. Malone F.D., Canick J.A., Ball R.H., Nyberg D.A., Comstock C.H., Bukowski R., et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005, 353:2001-2011.
12. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007, 109:217-227. ACOG Committee on Practice Bulletins.
13. Lo Y.M., Corbetta N., Chamberlain P.F., Rai V., Sargent I.L., Redman C.W., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350:485-487.
14. Chiu R.W., Akolekar R., Zheng Y.W., Leung T.Y., Sun H., Chan K.C., et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011, 342:c7401.
15. Chiu R.W., Chan K.C., Gao Y., Lau V.Y., Zheng W., Leung T.Y., et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 2008, 105:20458-20463.
16. Chiu R.W., Sun H., Akolekar R., Clouser C., Lee C., McKernan K., et al. Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. Clin Chem 2010, 56:459-463.
17. Liang D., Lv W., Wang H., Xu L., Liu J., Li H., et al. Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing. Prenat Diagn 2013, 33:409-415.
18. Shaw S.W., Hsiao C.H., Chen C.Y., Ren Y., Tian F., Tsai C., et al. Noninvasive prenatal testing for whole fetal chromosomal aneuploidies: a multicentre prospective cohort trial in Taiwan. Fetal Diagn Ther 2013, 10.1159/000355407.
19. Cuckle H.S., Wald N.J., Lindenbaum R.H. Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome. Lancet 1984, 1:926-929.
20. Cuckle H.S., Wald N.J., Thompson S.G. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 1987, 94:387-402.
21. Tseng J.J., Chou M.M., Lo F.C., Lai H.Y., Chen M.H., Ho E.S. Detection of chromosome aberrations in the second trimester using genetic amniocentesis: experience during 1995-2004. Taiwan J Obstet Gynecol 2006, 45:39-41.
22. Wald N.J., Rodeck C., Hackshaw A.K., Rudnicka A. SURUSS in perspective. BJOG 2004, 111:521-531.
23. Snijders R.J., Noble P., Sebire N., Souka A., Nicolaides K.H. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998, 352:343-346.
24. Nicolaides K.H., Azar G., Byrne D., Mansur C., Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992, 304:867-869.
25. Wald N.J., Hackshaw A.K. Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome. Prenat Diagn 1997, 17:821-829.
26. Tsai M.S., Huang Y.Y., Hwa K.Y., Cheng C.C., Lee F.K. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening. J Formos Med Assoc 2001, 100:319-325.
27. Chou C.Y., Hsieh F.J., Cheong M.L., Lee F.K., She B.Q., Tsai M.S. First-trimester Down syndrome screening in women younger than 35 years old and cost-effectiveness analysis in Taiwan population. J Eval Clin Pract 2009, 15:789-796.
28. Cheng P.J., Huang S.Y., Shaw S.W., Chueh H.Y., Hsieh T.T. Maternal homocysteine level and markers used in first-trimester screening for fetal Down syndrome. Reprod Sci 2010, 17:1130-1134.
29. Yang P.Y., Wu J.L., Yeh G.P., Tsung-Che Hsieh C. Three-dimensional ultrasonography measurement of fetal nasal bone length during the midtrimester in Taiwanese women. Taiwan J Obstet Gynecol 2012, 51:354-358.
30. Gilbert R.E., Augood C., Gupta R., Ades A.E., Logan S., Sculpher M., et al. Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies. BMJ 2001, 323:423-425.
31. Hwa H.L., Yen M.F., Lin C.L., Ko T.M., Hsieh F.J., Chen T.H. Cost-effectiveness analysis of triple test in second-trimester maternal serum screening for Down's syndrome: an experience from Taiwan with decreasing birth rate but increasing population of old pregnant women. J Eval Clin Pract 2008, 14:191-197.
32. Wald N.J., Densem J.W., George L., Muttukrishna S., Knight P.G. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn 1996, 16:143-153.
33. Hwa H.L., Huang L.H., Hsieh F.J., Chow S.N. Informed consent for antenatal serum screening for Down syndrome. Taiwan J Obstet Gynecol 2010, 49:50-56.
34. Benn P., Cuckle H., Pergament E. Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound Obstet Gynecol 2013, 42:15-33.
35. Lun F.M., Chiu R.W., Allen Chan K.C., Yeung Leung T., Kin Lau T., Dennis Lo Y.M. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem 2008, 54:1664-1672.
36. Fan H.C., Blumenfeld Y.J., Chitkara U., Hudgins L., Quake S.R. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 2008, 105:16266-16271.
37. Ehrich M., Deciu C., Zwiefelhofer T., Tynan J.A., Cagasan L., Tim R., et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011, 204:205. e1-11.
38. Palomaki G.E., Kloza E.M., Lambert-Messerlian G.M., Haddow J.E., Neveux L.M., Ehrich M., et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011, 13:913-920.
39. Bianchi D.W., Platt L.D., Goldberg J.D., Abuhamad A.Z., Sehnert A.J., Rava R.P., et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012, 119:890-901.
40. Ashoor G., Syngelaki A., Wagner M., Birdir C., Nicolaides K.H. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012, 206:322. e1-5.
41. Sparks A.B., Struble C.A., Wang E.T., Song K., Oliphant A. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012, 206:319. e1-9.
42. Norton M.E., Brar H., Weiss J., Karimi A., Laurent L.C., Caughey A.B., et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012, 207:137. e1-8.
43. Palomaki G.E., Deciu C., Kloza E.M., Lambert-Messerlian G.M., Haddow J.E., Neveux L.M., et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012, 14:296-305.
44. Committee Opinion No. 545: noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012, 120:1532-1534. American College of Obstetricians and Gynecologists Committee on Genetics.